{"id":1106360,"title":"DSEN Abstract: Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-27","captureTimestamp":"2026-02-27T10:50:01.205000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54496.html?wbdisable=true","snippet":"DSEN Abstract Crizotinib and Incidence of Death: A Systematic Review and Network Meta-analysis of ALK Inhibitors for Non-small Cell Lung Cancer Summary We observed that all ALK inhibitors improved progression-free survival relative to chemotherapy, and that alectinib and…","rawSnapshotUrl":"/api/snapshots/raw/1106360","browseUrl":"https://replay.healtharchive.ca/job-8/20260227105001/https://cihr-irsc.gc.ca/e/54496.html?wbdisable=true#ha_snapshot=1106360","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}